NEW YORK, March 28, 2018 /PRNewswire/ —  According to a report published by Arcview Market Research, in partnership with BDS Analytics, the worldwide consumer spending on legal cannabis is projected to reach $57 billion by 2027. North American is expected to have the largest spending volume, growing at compound annual growth rate of 18 percent to reach $47.3 billion during the forecast yeas. While the Rest of World (RoW) markets are expected to grow at a faster rate of 47 percent. The report indicated that total legal cannabis spending in Australia is forecast to grow from $52 million in 2018 to $1.2 billion in 2027, a CAGR of 53%, making is the 5th largest market in the world. In Europe, Germany is the leading in the legal cannabis market, while Italy is expected to reach $1.2 billion in sale by 2027. Liberty Health Sciences Inc. (OTC: LHSIF), MedReleaf Corp. (OTC: MEDFF), Kush Bottles, Inc. (OTC: KSHB), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), General Cannabis Corp. (OTC: CANN)

Viridian Capital President Scott Greiper told Benzinga that the cannabis industry received $1.23 billion investments in the first five weeks of 2018, up from $178 million a year earlier. Viridian Capital Advisors’ Vice President Harrison Phillips said: “Investments in cultivation and retail this year have been driven predominantly by the Canadian player. This has been happening pretty consistently from late 2016 through 2017. This reflects the necessity to scale cannabis businesses, to get some kind of advantage, and to explore strategic opportunities, both through acquisitions and international expansion.”

Liberty Health Sciences Inc. (OTCQX: LHSIF) also listed on the Canadian Securities Exchange under the Ticker (CSE: LHS). After the market close yesterday the company announced breaking news that, “it has agreed to acquire a 75% ownership interest (the “Transaction”) in

Read More Here...